Cliff Asness's IBB Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 5,162 shares of iShares Biotechnology ETF (IBB) worth $745,238, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 1,806 shares. Largest reduction occurred in Q1 2025, reducing 11,626 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +15,183 | New Buy | 15,183 | $126.96 |
| Q3 2023 | -15,183 | Sold Out | 15,183 | $126.96 |
| Q1 2025 | +3,557 | New Buy | 3,557 | $127.90 |
| Q2 2025 | +1,806 | Add 50.77% | 5,363 | $126.51 |
| Q3 2025 | -201 | Reduce 3.75% | 5,162 | $144.37 |
Cliff Asness's iShares Biotechnology ETF Investment FAQs
Cliff Asness first purchased iShares Biotechnology ETF (IBB) in Q2 2023, acquiring 15,183 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held iShares Biotechnology ETF (IBB) for 10 quarters since Q2 2023.
Cliff Asness's largest addition to iShares Biotechnology ETF (IBB) was in Q2 2023, adding 15,183 shares worth $1.93 M.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 5,162 shares of iShares Biotechnology ETF (IBB), valued at approximately $745,238.
As of the Q3 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in iShares Biotechnology ETF (IBB) was 15,183 shares, as reported at the end of Q2 2023.